What is insider trading data?

Insider trading data comes from SEC Form 4 filings, which corporate insiders must file within 2 business days of buying or selling company stock. This includes CEOs, CFOs, directors, and major shareholders.

How do I track congressional stock trades?

InsiderStreet.ai aggregates financial disclosures from the STOCK Act, showing stock trades by members of Congress. These are typically disclosed within 45 days of the transaction.

What are 13F filings?

13F filings are quarterly reports that institutional investment managers with over $100 million in assets must file with the SEC, revealing their equity holdings.

CBIO - Crescent Biopharma, Inc.

Name: Crescent Biopharma, Inc. (CBIO) Financial Data
Creator: InsiderStreet.ai
License: https://insiderstreet.ai/terms

$10.90

+0.28 (+2.64%)

After Hours: $11.31 (+0.41, +3.76%)

NASDAQ · Healthcare · Biotechnology · $300.4M · Alpha Radar Neutral · Power 53

Smart Money Score

Watch 25

Insider+$33.2M

Congress—

ETF Holdings—

Key Statistics

Market Cap$300.4M

52W Range8.72-29

Volume182,081

Avg Volume169,569

Beta1.30

Dividend—

Analyst Ratings

9 Buy 4 Hold 0 Sell

Consensus Buy

Company Info

CEOJoshua T. Brumm

Employees41

SectorHealthcare

IndustryBiotechnology

IPO Date2014-01-10

Websitecrescentbiopharma.com

300 Fifth Avenue
Waltham, MA 02451
US

617-430-5595

About Crescent Biopharma, Inc.

Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates. Its pipeline includes CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics, including novel combinations. The company is headquartered in Waltham, Massachusetts.

Latest News

HC Wainwright Has Optimistic Outlook of CBIO Q1 Earnings

Bullish DefenseWorld · 2w ago

Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Bullish GlobeNewsWire · 3w ago

Crescent Biopharma to Present at March Investor Conferences

GlobeNewsWire · 3w ago

Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

GlobeNewsWire · 6w ago

Crescent Biopharma, Inc. (NASDAQ:CBIO) Given Average Recommendation of “Buy” by Brokerages

Bullish DefenseWorld · 6w ago

Recent Insider Trades

Name	Type	Shares	Price	Date
McNeill Jonathan	A-Award	19,507	—	2025-12-15
McNeill Jonathan	A-Award	6,000	—	2025-12-15
McNeill Jonathan	A-Award	78,029	$13.21	2025-12-15
Im Ellie Eunkyung	A-Award	16,298	—	2025-12-15
Im Ellie Eunkyung	A-Award	5,000	—	2025-12-15

CBIO

Recent Insider Trades

Sign in to InsiderStreet